SynopsisThe global market for Protein Crystallization and Crystallography was valued at US$ 2052 million in the year 2024 and is projected to reach a revised size of US$ 3294 million by 2031, growing at a CAGR of 7.1% during the forecast period. The Global Prote.....
SynopsisThe global market for Acetazolamide Tablets was valued at US$ 97 million in the year 2024 and is projected to reach a revised size of US$ 142 million by 2031, growing at a CAGR of 5.5% during the forecast period. Acetazolamide is a diuretic medication th.....
SynopsisThe global market for Veterinary Antibacterial Prescription Drugs was valued at US$ 4980 million in the year 2024 and is projected to reach a revised size of US$ 6732 million by 2031, growing at a CAGR of 4.4% during the forecast period. Veterinary antib.....
SynopsisThe global market for Dental X-ray Tube was valued at US$ 232 million in the year 2024 and is projected to reach a revised size of US$ 373 million by 2031, growing at a CAGR of 7.1% during the forecast period. An X-ray tube is an energy converter. It rec.....
SynopsisThe global market for Antimicrobial Peptides was valued at US$ 5.5 million in the year 2024 and is projected to reach a revised size of US$ 8 million by 2031, growing at a CAGR of 5.4% during the forecast period. Antimicrobial peptides (AMPs), also calle.....
SynopsisThe global market for Buspirone Hydrochloride Tablets was valued at US$ 113 million in the year 2024 and is projected to reach a revised size of US$ 164 million by 2031, growing at a CAGR of 5.4% during the forecast period. Buspirone hydrochloride tablet.....
SynopsisThe global market for Platelet-derived Growth Factor Reagent was valued at US$ 112 million in the year 2024 and is projected to reach a revised size of US$ 190 million by 2031, growing at a CAGR of 8.0% during the forecast period. Platelet-derived growth.....
SynopsisThe global market for Central Venous Access Devices was valued at US$ 1756 million in the year 2024 and is projected to reach a revised size of US$ 2363 million by 2031, growing at a CAGR of 4.4% during the forecast period. Central venous access devices .....
SynopsisThe global market for Pilocarpine Hydrochloride Ophthalmic Solution was valued at US$ 85.6 million in the year 2024 and is projected to reach a revised size of US$ 146 million by 2031, growing at a CAGR of 7.8% during the forecast period. Pilocarpine oph.....
SynopsisThe global market for Neurorehabilitation was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. North American market for Neurorehabilitation is estim.....
